Technical Analysis for PLXP - PLx Pharma Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Historical PLXP trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Expansion Breakdown | Bearish Swing Setup | 2.81% | |
| Expansion Pivot Sell Setup | Bearish Swing Setup | 2.81% | |
| Volume Surge | Other | 2.81% | |
| Wide Range Bar | Range Expansion | 2.81% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Down 5% | 3 days ago |
| Down 3% | 3 days ago |
| Down 2 % | 3 days ago |
| 60 Minute Opening Range Breakdown | 3 days ago |
| Expansion Pivot Sell Entry | 3 days ago |
Free Daily (Stock) Chart Reading
- Earnings date: 11/15/2021
PLx Pharma Inc. Description
PLx Pharma Inc., formerly Dipexium Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is a late stage specialty pharmaceutical company focusing on commercializing its lead products: Aspertec 325 mg and Aspertec 81 mg (Aspertec). The Company’s products and technology includes PLxGuard delivery system, Aspertec 325 mg, PL1100/PL1200 Ibuprofen. PLxGuard delivery system uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs to selectively release these drugs to targeted portions of the GI tract. The Company’s lead product Aspertec 325 mg is a liquid-fill aspirin capsule for prevention of cardiovascular disease. Through PLxGuard delivery system the Company creates a lipid-based formulation of ibuprofen, PL1200 Ibuprofen Capsules, 200 mg.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Acid Drugs Organic Compounds Cardiovascular Disease Lipid Acids Analgesics Fatty Acid Stage Specialty Pharmaceutical Hepatotoxins Fatty Acids Lipids Carboxylic Acids Ibuprofen Aspirin
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 21.5 |
| 52 Week Low | 3.0 |
| Average Volume | 412,897 |
| 200-Day Moving Average | 12.54 |
| 50-Day Moving Average | 17.79 |
| 20-Day Moving Average | 18.31 |
| 10-Day Moving Average | 17.31 |
| Average True Range | 1.36 |
| ADX | 18.58 |
| +DI | 14.33 |
| -DI | 39.10 |
| Chandelier Exit (Long, 3 ATRs) | 17.11 |
| Chandelier Exit (Short, 3 ATRs) | 16.73 |
| Upper Bollinger Bands | 22.07 |
| Lower Bollinger Band | 14.55 |
| Percent B (%b) | -0.08 |
| BandWidth | 41.05 |
| MACD Line | -0.72 |
| MACD Signal Line | -0.06 |
| MACD Histogram | -0.6548 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 16.35 | ||||
| Resistance 3 (R3) | 16.20 | 15.24 | 15.94 | ||
| Resistance 2 (R2) | 15.24 | 14.62 | 15.31 | 15.81 | |
| Resistance 1 (R1) | 14.58 | 14.24 | 14.91 | 14.73 | 15.67 |
| Pivot Point | 13.62 | 13.62 | 13.79 | 13.70 | 13.62 |
| Support 1 (S1) | 12.96 | 13.00 | 13.29 | 13.11 | 12.17 |
| Support 2 (S2) | 12.00 | 12.62 | 12.08 | 12.03 | |
| Support 3 (S3) | 11.34 | 12.00 | 11.90 | ||
| Support 4 (S4) | 11.49 |
